Compare PRCT & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCT | CRAI |
|---|---|---|
| Founded | 2009 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2021 | 1998 |
| Metric | PRCT | CRAI |
|---|---|---|
| Price | $17.56 | $178.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 2 |
| Target Price | $22.25 | ★ $250.50 |
| AVG Volume (30 Days) | ★ 1.3M | 87.5K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | 1.71 | ★ 20.77 |
| EPS | N/A | ★ 8.14 |
| Revenue | $308,054,000.00 | ★ $751,583,000.00 |
| Revenue This Year | $28.32 | $8.35 |
| Revenue Next Year | $20.48 | $4.01 |
| P/E Ratio | ★ N/A | $21.75 |
| Revenue Growth | ★ 37.22 | 9.33 |
| 52 Week Low | $16.67 | $132.17 |
| 52 Week High | $38.11 | $227.29 |
| Indicator | PRCT | CRAI |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 59.92 |
| Support Level | $16.84 | $153.02 |
| Resistance Level | $29.27 | $178.61 |
| Average True Range (ATR) | 0.99 | 5.19 |
| MACD | 0.12 | 0.88 |
| Stochastic Oscillator | 35.14 | 78.43 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.